When tested with BCR-ABL protein, one of the most potent anti-apoptotic proteins in CML [32], compounds 1–4 could not bind in the same central cavity as this inhibitor (also occupied by the nucleoside portion of ATP). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.